Videos by Topic


Addiction | Alcohol | Drugs

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Adolescents

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Athletics | Exercise

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Pregnancy

The process by which a female produces an offspring in their womb once the male and female zygotes have combined into a single embryo until birth.

Embryo

The offspring in the womb, from the moment 2 zygotes co-exist up until the 11th week of pregnancy, is medically referred to as "Embryo"

Fetus

The offspring in the womb, beginning on the 11th week of pregnancy, has graduated from "Embryo" to "Fetus"

Newborn

The offspring, now emerged from the womb and ending the female's pregnancy.

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Cancer

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Children

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

COVID-19

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Disease

An abnormality caused due to pathophysiological response to external or internal factors.

Disorder

A disruption in normal functioning of mind or body due to a disease, genetic factor or trauma.

Syndrome

A set or collection of various identifying signs and symptoms that characterizes a certain disease or disorder.

Condition

An abnormal state of physical or mental health that interferes with usual activities or the feeling of well-being.

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Food | Obesity

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Girls ♀ Women

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Infections | Immune System

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Injury | Pain | Violence

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Medication | Treatment | Therapy | Surgery

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Mental Health | Wellbeing | Stress | Sleep

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Myths | Fake News | Science Mistrust

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Physical Health | Human Body | Sex

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Products | Supplements

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Racism | Inequality

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Science

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

Technology

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 

YouTube #Shorts

The Galleri Test

Apr 13, 2022, 13:45 PM by Helly Shah, Talia Amir, Alexandro Chu, Keny Patel, and Srustie Patel
The Galleri test is a promising alternative screening test for certain types of cancers that has yet to be cleared by the FDA.

Cancer is a disease that affects millions of individuals around the world annually. Traditional cancer detection procedures are time-consuming, and often associated with an increase in personal and economic burden. The Galleri test is an alternative screening test with promising results. Individuals eligible for the Galleri test include adults with an elevated risk for cancer, individuals aged 50 and older, and individuals experiencing cancer symptoms. This multi-cancer early detection (MCED) test relies on circulating tumour cell-free DNA (cfDNA) in the bloodstream to detect over 52 types of cancer.

In most cancer types, the detectability increases with cancer stage as the proportion of cfDNA in the bloodstream also increases with the cancer stage. Results from the test are received in 2 weeks following the blood draw and should be interpreted by your healthcare provider.

Although the Galleri test has promising results, it brings with it a few limitations. The Galleri test does not detect all cancers, the test does not measure your genetic risk of developing cancer in the future, the test has not been cleared by the FDA, and most importantly, it should be used in addition to other screening procedures. 

Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/Demystifyin...

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]









 




 



Accessibility for Ontarians With Disabilities Act (AODA)

 

The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at fhsaoda@mcmaster.ca.